Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small-cell lung cancer will benefit from immunotherapy.

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.

Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.

Key HighlightsResearchers identified distinct tumor-immune ecologies that differentiate stable disease from progressive disease in non-small cell lung ...

A, B: Two resting state networks are altered in babies with congenital heart disease preoperation, but after surgery these ...

In disease research, it's important to know gene expression and where in a tissue the expression is happening, but marrying the two sets of information can be challenging. Single-cell technologies, ...

Up to half of patients with Crohn's disease, an inflammatory bowel disease, develop a complication called fibrosis, where the gut becomes scarred and obstructed, causing pain and bloating. Currently, ...

Early detection and molecular characterization of disease progression are persistent challenges in modern medicine. Although genomic and transcriptomic profiling of tissue lesions and precursors has ...

A new study from researchers at the Hebrew University of Jerusalem provides fresh insight into how pancreatic cancer may ...

A new AI-based method reconstructs spatial information about where immune cells were originally located in an organ, even after these cells have been removed from the tissue and analyzed individually.